CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products.

MLA

Kath, Jonas, et al. “CAR NK-92 Cell-Mediated Depletion of Residual TCR+ Cells for Ultrapure Allogeneic TCR-Deleted CAR T-Cell Products.” Blood Advances, vol. 7, no. 15, Aug. 2023, pp. 4124–34. EBSCOhost, https://doi.org/10.1182/bloodadvances.2022009397.

APA

Kath, J., Du, W., Martini, S., Elsallab, M., Franke, C., Hartmann, L., Drosdek, V., Glaser, V., Stein, M., Schmueck-Henneresse, M., Reinke, P., Volk, H.-D., Abou-El-Enein, M., & Wagner, D. L. (2023). CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products. Blood Advances, 7(15), 4124–4134. https://doi.org/10.1182/bloodadvances.2022009397

Chicago

Kath, Jonas, Weijie Du, Stefania Martini, Magdi Elsallab, Clemens Franke, Laura Hartmann, Vanessa Drosdek, et al. 2023. “CAR NK-92 Cell-Mediated Depletion of Residual TCR+ Cells for Ultrapure Allogeneic TCR-Deleted CAR T-Cell Products.” Blood Advances 7 (15): 4124–34. doi:10.1182/bloodadvances.2022009397.